IL6 and juvenile idiopathic arthritis: This resulted in therapeutic treatments focusing on the pathogenesis of JIA, specifically the proinflammatory cytokines such as tumour necrosis factor alpha [TNFα], interleukin-1 [IL-1], and interleukin-6 [IL-6]; and the signalling mediators that regulated the B-cell and T-cell lymphocytes [34].